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Summary
Objectives:  Still  today,  Menière’s  disease  (MD)  can  be  deﬁnitively  diagnosed  only  on  post-
mortem ﬁndings  of  endolymphatic  hydrops.  Otoacoustic  emission  (OAE)  phase  has  been  shown
to be  highly  sensitive  to  intracranial  pressure.  Preliminary  analysis  of  OAEs  in  MD  patients  indi-
cated high  sensitivity  to  slight  variations  in  intracranial  pressure.  The  principal  objective  of  the
present study  was  to  conﬁrm  this  speciﬁc  sensitivity  of  OAEs  in  MD.
Patients and  methods:  In  a  prospective  study  of  32  consecutive  cases  of  acute  MD  seen  in
consultation  or  hospital,  20  patients  (23  ears)  underwent  acoustic  phase-shift  test:  i.e.,  seated
vs. supine  OAE  phase  centered  around  1  kHz,  with  results  compared  to  controls.
Results:  The  acoustic  phase-shift  test  was  performed  in  62.5%  of  acute  patients  (58.9%  of
affected ears).  In  the  control  group,  the  95%  conﬁdence  interval  for  phase  shift  was  between
—30◦ and  +45◦.  Phase  shift  was  signiﬁcantly  elevated,  beyond  the  normal  interval,  in  18  of  the
MD patients:  range,  —80◦ to  +145◦.  Sensitivity  was  90%.  Overall,  in  patients  in  whom  transient
evoked OAEs  (TEOAEs)  were  present,  positive  predictive  value  was  100%  and  negative  predictive
value 92.3%.
Conclusions:  The  acoustic  phase-shift  test  proved  useful  and  powerful  in  demonstrating  pres-
sure imbalance  in  acute  Menière’s  disease.
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IntroductionThe  diagnosis  of  Menière’s  disease  (MD)  is  basically  clini-
cal.  Since  ﬁrst  described  in  1861  by  Prosper  Menière,  it  has
∗ Corresponding author.
E-mail address: tmom@chu-clermontferrand.fr (T. Mom).
p
o
i
A
s
o
t
1879-7296/$ – see front matter © 2011 Published by Elsevier Masson SAS
doi:10.1016/j.anorl.2011.07.004sson  SAS.
een  related  to  ‘‘hydrops’’:  considerably  elevated  endolym-
hatic  liquid  volume  in  the  scala  media.  Demonstration  can
nly  be  histologic:  i.e.,  post-mortem;  visualizing  the  hydrops
s  the  only  formal  proof  of  MD  according  to  the  American
cademy  of  Otolaryngology-Head  and  Neck  Surgery  consen-
us  report  [1].  In  clinical  practice,  MD  is  diagnosed  in  case
f  a  triad  comprising  vertigo,  tinnitus  and  hearing  loss,  ﬂuc-
uating  over  time  with  acute  phases  of  variable  frequency
.
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nd  intensity.  Obviously,  other  etiologies  (neurodegenera-
ive  or  tumoral)  need  to  be  ruled  out.  Objectively,  it  remains
mpossible  to  visualize  hydrops  in  a  living  subject  in  rou-
ine  practice.  Indirect  evidence  from  electrophysiology  has
een  recommended.  One  such  marker,  generally  admitted
o  be  sure,  is  an  altered  relation  between  cochlear  sum-
ating  and  composite  action  potentials  (SP/AP)  [2]:  AP,
nlike  SP,  is  only  weakly  altered  by  hydrops,  resulting  in
n  SP/AP  ratio  exceeding  0.4.  Due  to  several  reservations,
owever,  electrocochleography  is  in  fact  little  used  to  diag-
ose  MD  in  clinical  practice.  To  be  reliable,  recording  used
o  require  a  transtympanic  electrode,  making  the  proce-
ure  invasive.  Above  all,  it  was  later  reported  that  the
P/AP  ratio  was  in  fact  poorly  correlated  to  clinical  data
nd  had  little  diagnostic  value,  mainly  due  to  poor  sensi-
ivity  [3].  Aside  from  electrocochleography,  other  methods
ave  been  described:  notably,  analysis  of  tympanic  motion
nd  of  tympano-ossicular  system  rigidity.  The  Marchbanks
est  of  tympanic  membrane  displacement  using  the  MMS-
0® analyzer,  introduced  in  1982,  was  based  on  calculating
he  displacement  of  the  stapes  footplate  towards  the  cavum
ympani  associated  with  hydrops  [4].  The  technique,  how-
ver,  ﬁnally  showed  very  poor  sensitivity,  at  around  50%
ccording  to  Bouccarra  et  al.  (1998)  [5];  in  the  same  year,
osingh  et  al.  found  no  signiﬁcant  difference  between  con-
rol  and  MD  subjects  on  the  Marchbanks  test  [6].
Another  means  of  indirect  exploration  of  intral-
byrinthine  pressure  was  described  in  2005  by  Franco-Vidal
t  al.  [7]:  conductance  recording  at  2  kHz  showed  56.5%  pos-
tive  tests  in  affected  ears  in  MD  patients  and  45.8%  in  the
ontralateral  ear,  versus  5%  in  controls.  Thus,  in  practice,
his  test  shows  negative  in  almost  half  of  proven  cases  of
D,  and  cannot  contribute  to  diagnosis.
Considering  the  high  sensitivity  of  otoacoustic  emissions
OAEs)  to  intracranial  pressure  variation  [8]  and  possible
ensitivity  to  cochlear  hydrops  and  related  phenomena  [9],
e  recently  reported  that,  while  glycerol  had  a  clear  impact
n  intracranial  pressure,  there  was  no  signiﬁcant  difference
n  response  to  glycerol  between  affected  and  asymptomatic
ars  in  MD  [10]. Brieﬂy,  transient  evoked  OAE  (TEOAE)
hase  was  compared  between  two  postural  situations  for
requencies  between  0  and  6  kHz:  TOEAE  phase  shift  at
 kHz  between  the  seated  and  supine  position  was  signiﬁ-
antly  greater  on  the  affected  than  on  the  asymptomatic
ide  in  all  patients.  This  was  likely  due  to  intracranial  pres-
ure  elevation  induced  by  lowering  the  head.  Assuming  the
atients  to  have  hydrops,  intracochlear  pressure  would  be
reatly  increased.  A  slight  change  in  intracranial  pressure,
s  induced  by  the  postural  change  from  seated  to  supine,
ould  affect  the  inner  ear,  inducing  a  marked  shift  in  TEOAE
hase  at  1  kHz,  mimicking  the  effect  of  a  much  stronger  rise
n  intracranial  pressure  in  a  healthy  inner  ear.  These  ﬁndings
hould  be  conﬁrmed,  as  this  property  of  TEOAEs  would  be
f  great  use  in  diagnosing  MD.  The  present  study  compared
osture-linked  TEOAE  phase  shift  in  an  MD  and  a  control
opulation.aterials and methods
atients  were  included  if  presenting  with  a  clinical  triad
ssociating  vertigo,  tinnitus  and  partial  hearing  loss,  with
b
m
i
Tigure  1  Mean  ±  SD  in  Menière’s  disease  patients  on  acoustic
hase-shift  test.
earing  ﬂuctuating  over  time  and  vertigo  showing  acute
ttacks.  Classic  tonal  (Fig.  1)  and  vocal  audiometry  were
erformed.  Cranial  MRI  conﬁrmed  absence  of  any  intracra-
ial  pathology  underlying  the  presenting  symptoms.  TEOAEs
ere  recordable  in  all  subjects.  In  all  MD  patients,  the
coustic  TEOAE  phase-shift  test  was  performed  on  both  ears
uring  a  period  that  was  clinically  positive  (with  at  least  one
f  the  triad  of  signs)  or  acute  (with  all  three  of  the  triad  of
igns)  and  never  during  remission.
For  the  acoustic  TEOAE  phase-shift  test,  TEOAEs  were
ecorded  using  David  T.  Kemp’s  ILO  99  apparatus.  Each
ecording  comprised  the  mean  of  260  responses  to  click  stim-
li;  to  be  valid,  the  mean  response  above  the  noise  ﬂoor  was
equired  to  show  a  reproducibility  coefﬁcient  greater  than
0%  on  a narrow  frequency  interval  centered  on  1  kHz  (typi-
ally,  0.8—1.2  kHz,  for  a  maximum  of  0.5—1.5  kHz).  Too  great
 deviation  from  this  frequency  range  could  bias  interpreta-
ion,  with  middle-ear  pressure  coming  into  play  [11]. TEOAEs
ere  recorded  in  both  ears,  with  all  patients  ﬁrst  seated  and
hen  supine.  TEOAE  phase  shift  between  seated  and  supine
alues  was  then  calculated  on  a  PC,  ear  by  ear  for  each
ubject,  following  a  method  already  used  in  osmosis  testing
n  our  center  [10]. Brieﬂy,  a  Fourier  transform  calculated
coustic  signal  phase  for  each  posture  around  1  kHz.
The  control  group  comprised  patients  without  otologic
istory  and  with  normal  hearing,  in  whom  the  acoustic
hase-shift  test  was  performed  in  at  least  one  ear.  The  con-
rol  phase-shift  values  determined  the  standard  deviation
SD)  of  the  TEOAE  phase-shift  for  the  chosen  interval  in
his  population.  Assuming  the  distribution  to  be  normal,  a
hase  shift  showing  more  than  two  SDs  from  the  mean  was
onsidered  abnormal  with  an  error  risk  of  5%.
The  control  group  comprised  23  subjects,  for  36  ears.
ean  TEOAE  phase  shift  was  6.6◦ with  SD  ±  17◦.  The  nor-
ality  interval  thus  ranged  from  —27.4◦ to  +40.6◦ (Fig.  2).
n  this  basis,  a range  of  variation  from  —30◦ to  +45◦ was
ccepted  as  normal  (thick  lines  in  Fig.  2),  with  a  95%  chance,
y  deﬁnition,  of  including  normal  cases.
Applied  to  the  MD  population,  the  test  was  considered
ositive  when  phase  shift  was  abnormal.
The  acoustic  phase-shift  test  results  were  compared
etween  the  two  populations  on  Student  t  test  for  non-
atched  series  and  between  the  two  ears  of  a  single  subject
n  a  given  population  on  Student  t  test  for  matched  series.
he  signiﬁcance  threshold  was  set  at  p<0.05.
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Figure  2  Control  otoacoustic  emission  acoustic  phase  shift  (degrees)  on  the  0.8—1.2  kHz  band  for  the  two  recording  postures
tangl
R
T
T(seated and  supine).  Blue  rectangles  show  phase  shift.  No  rec
show the  normal  phase-shift  interval.
No  patients  underwent  calibrated  caloric  testing  in
acute  phase,  for  obvious  clinical  reasons  so  as  to  avoid
serious  discomfort.  During  follow-up  or  previous  exami-
nations,  however,  all  at  one  point  or  another  underwent
vestibular  exploration  by  Barany’s  caloric  test,  which  in
all  cases  showed  vestibular  hyporeﬂexia  in  the  affected
ear.
f
I
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Figure  3  Otoacoustic  emission  acoustic  phase  shift  (degrees)  on
patients for  the  two  recording  postures  (seated  and  supine).  Blue  
phase-shift interval.e  indicates  zero  phase  shift  in  the  tested  ear.  The  thick  lines
esults
wenty  out  of  32  patients  with  evident  MD  (62.5%)  showed
EOAEs  and  could  undergo  phase-shift  testing:  16  female,
our  male;  mean  age,  51◦±13◦ years  (range,  27—75  years).
n  terms  of  tested  ears,  23  out  of  39  (58.9%)  showed  TEOAEs
nd  could  be  tested.  Fig.  3  shows  the  wide  OAE  phase
 the  0.8—1.2  kHz  band  in  affected  ears  of  Menière’s  disease
rectangles  show  phase  shift.  The  thick  lines  show  the  normal
e20  
Figure  4  Example  of  otoacoustic  emission  acoustic  phase
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phift on  the  0.8—1.2  kHz  band  between  seated  (black  line)  and
upine  (gray  line)  posture  in  acute  Menière’s  disease.
ariation  between  seated  and  supine  measures;  to  highlight
he  excess  variation  as  compared  to  control  values,  the  pre-
eﬁned  normal  range  is  shown  between  thick  lines.  Fig.  4
hows  an  example  of  phase  shift.  Mean  phase  variation  was
5.4◦±70.9◦ (range,  —80◦ to  +145◦)  in  this  population.
Tables  1  and  2  summarize  the  test  results,  by  patient
nd  by  ear,  respectively.  Positive  predictive  value  is  maxi-
al  at  100%  in  both  tables,  and  negative  predictive  value
2%.  Sensitivity  was  very  good,  at  almost  90%  in  both  tables
respectively  90%  and  86.9%).  Speciﬁcity  was  also  very  high,
t  100%.
Twenty-two  MD  patients  were  also  tested  in  their  con-
ralateral  ear,  which  was  completely  asymptomatic.  Mean
hase  shift  was  12.3±23.8◦ (range,  —40◦ to  +50◦).  These
ealthy  contralateral  ears  were  not  considered  as  pure  con-
rols,  as  MD  is  frequently  bilateral  or  becomes  so  over  time.
coustic  phase  shift  and  variability  can  be  seen  to  be  greater
n  MD  patients’  healthy  ears  than  in  those  of  control  sub-
ects;  two  ears  showed  non-normal  values  according  to  our
eﬁnition  (the  two  extreme  cases);  nevertheless  the  differ-
nce  between  the  two  groups  was  non-signiﬁcant  (p=0.293).
hase  shift,  however,  was  clearly  less  than  in  affected  ears,
here  it  markedly  exceeded  the  normal  conﬁdence  inter-
al;  the  difference  between  the  two  ears  of  unilateral  MD
atients  was  signiﬁcant  (p=0.0183).
Table  1  Contingency  table:  comparison  between  Menière’s
disease  (MD)  patients  and  controls.
Positive  test  Negative  test
MD  18  2
Control  0  23
Table  2  Contingency  table:  comparison  between  affected
ears in  Menière’s  disease  (MD)  patients  and  control  ears.
Positive  test  Negative  test
MD 20  3
Control  0  36
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iscussion
he  present  acoustic  phase-shift  test  proved  highly  sensi-
ive  when  performed  in  the  acute  phase;  to  the  best  of
ur  knowledge,  there  is  no  test  as  sensitive  and  speciﬁc  to
D  reported  in  the  literature.  It  is  important  to  recall  that
ll  patients  were  tested  in  the  midst  of  an  attack  of  MD
r  while  clinically  positive.  The  very  characteristically  ﬂuc-
uating  symptomatology  of  MD,  with  periods  of  complete
emission  at  least  during  the  early  stages  of  the  disease,
uggests  associated  ﬂuctuation  in  hydrops.  It  is  only  logical
or  a  test  intended  to  highlight  hydrops  to  show  results  that
uctuate  in  line  with  the  patient’s  experienced  symptoms.
lectrocochleography  may  prove  just  as  sensitive  and  spe-
iﬁc  if  implemented  exclusively  in  the  acute  phase,  but  that
emains  to  be  shown.
Acoustic  phase  shift  highlights  a variation  in  intracochlear
unctioning  that  is  worth  understanding.  By  analogy  to  what
s  observed  in  intracranial  pressure  variation  as  described
y  Büki  et  al.  [8],  it  is  logical  to  expect  a  marked  distur-
ance  in  intralabyrinthine  pressure.  Acoustic  phase  shift,
n  agreement  with  Zwislocki’s  model,  would  thus  reﬂect
 change  affecting  cochlea  and  stapes,  which  the  model
akes  as  a  whole  of  which  the  components  cannot  be  dis-
inguished  [12]. There  may  be  a  change  in  the  rigidity
f  the  annular  ligament  of  the  footplate  under  pressure
rom  the  perilymphatic  compartment  that  is  pushed  back  by
he  endolymphatic  compartment  containing  the  hydrops;  or
here  may  be  some  more  subtle  endocochlear  modiﬁcation.
he  endocochlear  pressure  resulting  from  change  of  posture
ould  be  the  equivalent  for  the  ‘‘hydropic’’  cochlea  of  a
onsiderable  rise  in  intracranial  pressure.  In  Büki  et  al.’s
xperiment,  the  functioning  of  a  normal  cochlea  reﬂected
hange  in  intracranial  pressure  [8].  In  MD,  however,  cochlear
unctioning  is  not  normal,  by  deﬁnition.  Is  Zwislocki’s  model
hen  non-applicable?  As  the  model  does  not  distinguish
hich  part  of  the  inner  ear  is  being  measured  but  considers
t  as  a  single  whole,  it  can  reasonably  be  considered  appli-
able  even  in  a  pathological  ear.  TEOAE  phase  change  in  a
est  performed  in  an  ear  affected  by  MD  during  the  acute
hase  may  be  attributed  to  the  hair  bundle  of  the  outer  hair
ells  (OHCs).  OHC  hair  bundle  inclination,  inducing  opening
f  speciﬁc  ion  channels,  compared  to  gating  springs,  deter-
ines  OHC  excitation  level  [13], which  in  turn  deﬁnes  the
HC  resting  point  which  may  shift  along  the  characteris-
ic  OHC  input-output  (I-O)  curve,  as  faithfully  reﬂected  in
he  amplitudes  of  some  types  of  OAE  (quadratic  distortion-
roduct  OAEs)  or  in  the  phase  of  others,  as  interests  us
ere  [14]. As  hydrops,  clearly  visible  on  available  histologic
ross-sections,  whether  human  or  from  animal  experiments
15,16],  can  considerably  deform  the  endolymphatic  com-
artment,  it  may  be  that  OHC  hair  bundle  inclination  is
uite  different  in  case  of  hydrops  and  subject  to  signiﬁcant
ariation  following  variations  in  hydrops  itself,  ﬂuctuating
ver  time  and  indeed  normalizing  when  hydrops  is  in  remis-
ion.  On  this  hypothesis,  postural  change  merely  reveals  a
hange  in  OHC  resting  point,  accentuating  the  deﬂection  of
he  hair  bundle.  Phase-shift  polarity  would  depend  upon  the
irection  of  OHC  resting  point  displacement  (along  the  I-O
urve).  We  have  as  yet  no  proof  of  this  hypothesis;  more  ﬁne-
rained  analysis  using  distortion-product  OAEs  might  provide
he  answer.
DT
c
R
[
[
[
[
[
[
[Acoustic  phase-shift  test  in  Menière’s  disease  
For  clinicians,  however,  the  great  sensitivity  and  speci-
ﬁcity  of  the  acoustic  phase-shift  test  remain  interesting.
The  very  high  levels  reported  here  are  of  course  to  be  set
against  the  relatively  small  size  of  the  sample.  Even  so,  the
MD  population  was  homogeneous.
The  test  provides  objective  evidence  of  changed  endo-
cochlear  functioning  in  acute  MD.  In  true  MD,  the  clinical
presentation  is  of  course  obvious,  but  it  is  always  reassuring
to  have  objective  arguments  for  any  dysfunction,  especially
where  aggressive  treatment  may  be  undertaken,  such  as
chemical  labyrinthectomy  or  vestibular  neurectomy.  Some
patients  also  suffer  from  ﬂuctuating  hypoacusis,  without
vestibular  signs.  Everything  points  to  a  physiopathological
similarity  between  such  ﬂuctuating  hearing  loss  and  MD:  i.e.,
hydrops,  sparing  the  vestibule.  House  et  al.  (2006)  did  not
hesitate  to  speak  of  ‘‘cochlear  hydrops’’  [17]. Thirty-three
percent  of  their  cochlear  hydrops  cases  developed  into  true
MD  in  a  mean  seven  years.  Here,  the  acoustic  phase-shift  test
should  prove  very  useful  in  demonstrating  the  endocochlear
dysfunction  typically  associated  with  hydrops.
Another  noteworthy  ﬁnding  was  the  greater  postural  OAE
phase  variation  in  the  asymptomatic  contralateral  ear  of
MD  patients  as  compared  to  controls,  although  remaining
within  normal  limits.  Statistically,  the  difference  was  non-
signiﬁcant  overall;  but  two  patients  showed  values  outside
normal  limits:  i.e.  9%  (2/22),  which  was  more  than  the
acceptable  value  (deﬁned  as  5%).  Recall  here  the  high  rate
of  bilateral  MD  at  initial  diagnosis,  and  the  large  num-
ber  of  patients  undergoing  bilateralization  during  evolution
of  MD,  estimated  at  respectively  11%  and  14%  by  House
et  al.  in  2006,  with  a  total  23%  bilateral  involvement  during
the  course  of  evolution  [17]. The  acoustic  phase-shift  test
could  check  contralateral  cochlear  normality  in  MD  before
recommending  aggressive  treatment  abolishing  vestibular
information.
The  acoustic  phase-shift  test,  however,  is  not  always
applicable,  requiring  analyzable  TEOAEs  within  a  narrow  fre-
quency  band  around  1  kHz.  Thus,  for  example,  it  cannot  be
applied  in  longstanding  MD  with  severe  hearing  loss.  In  our
experience,  it  is  applicable  in  just  under  two  thirds  of  cases
(62.5%).
Conclusion
It  is  sure  that  the  acoustic  phase-shift  test  shows  disturbance
in  MD.  It  provides  the  clinician  with  a  precious  objec-
tive  argument  to  determine  treatment  strategy.  It  should
also  shed  light  on  the  physiopathology  of  certain  condi-
tions  probably  related  to  MD  but  clinically  incomplete,  such
as  recurrent  vertigo  without  auditory  signs,  or  conversely
ﬂuctuating  hearing  loss  without  vestibular  signs,  presently
referred  to  as  cochlear  hydrops.  This  acoustic  phase-shift
test  should  allow  the  efﬁcacy  of  a  given  treatment  strategy
to  be  assessed.
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